Following allergy death, MKs address Health Ministry for policy changes
Several MKs have suggested different policies in order to best prevent cases of allergy deaths in the future.
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. (photo credit: JIM BOURG / REUTERS)
